Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$812
|
$764B |
14.8x |
37.4x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$192
|
$405B |
7.0x |
15.4x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$157
|
$390B |
4.3x |
12.0x |
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 519
|
$364B |
7.7x |
15.7x |
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 275
|
$289B |
3.9x |
9.8x |
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 98
|
$259B |
4.8x |
11.6x |
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£109
|
$255B |
4.4x |
12.8x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$82
|
$231B |
3.6x |
8.4x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$297
|
$208B |
6.1x |
11.0x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$185B |
2.9x |
7.6x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$112
|
$156B |
5.4x |
12.6x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$51
|
$143B |
3.0x |
12.1x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€87
|
$135B |
2.6x |
8.9x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$460
|
$114B |
9.9x |
39.0x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£15
|
$102B |
2.4x |
6.9x |
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 241
|
$85.8B |
5.5x |
16.6x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$169
|
$80.2B |
8.6x |
19.9x |
Chugai Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 7549
|
$79.8B |
9.6x |
19.4x |
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4375
|
$76.1B |
2.4x |
9.3x |
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€28
|
$68.2B |
1.3x |
6.2x |
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€116
|
$65.5B |
2.7x |
9.4x |
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 583
|
$55.3B |
6.4x |
22.6x |
Jiangsu Hengrui
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 56
|
$47.8B |
11.7x |
44.3x |
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1687
|
$44.4B |
7.1x |
25.0x |
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3611
|
$42.4B |
3.2x |
15.5x |
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 62
|
$35.3B |
2.1x |
7.2x |
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 163900
|
$27.8B |
9.8x |
32.2x |
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 43
|
$26.2B |
2.4x |
11.7x |
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 7391
|
$25.9B |
1.6x |
6.9x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$24.1B |
1.7x |
5.5x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$132
|
$23.4B |
2.5x |
7.3x |
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 8
|
$22.3B |
2.2x |
6.4x |
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1417
|
$21.9B |
1.6x |
8.8x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$35
|
$20.7B |
7.2x |
7.7x |
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 30
|
$19.4B |
10.9x |
28.9x |
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 338
|
$18.7B |
32.1x |
67.2x |
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€9
|
$17.7B |
2.1x |
8.5x |
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 81
|
$16.2B |
11.2x |
333.5x |
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 410500
|
$15.6B |
125.7x |
328.5x |
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€55
|
$15.3B |
5.4x |
14.6x |
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3259
|
$13.1B |
9.6x |
29.3x |
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1363
|
$13.1B |
3.4x |
12.7x |
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1502
|
$12.9B |
4.0x |
15.5x |
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 57
|
$12.3B |
2.2x |
15.5x |
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 6
|
$12.3B |
2.9x |
12.7x |
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2387
|
$12.2B |
8.2x |
32.5x |
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 9
|
$12.1B |
3.0x |
12.4x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$125
|
$11.9B |
4.7x |
19.1x |
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 293
|
$11.8B |
4.2x |
11.5x |
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 24
|
$11.7B |
2.0x |
12.3x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$11.0B |
1.7x |
5.7x |
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 1484
|
$10.9B |
3.2x |
9.2x |
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 979
|
$10.9B |
4.0x |
13.5x |
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 2022
|
$10.9B |
4.0x |
16.9x |
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 45
|
$10.8B |
1.8x |
14.2x |
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 95
|
$10.5B |
27.0x |
-1183.5x |
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€64
|
$10.3B |
5.7x |
17.8x |
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2458
|
$10.2B |
3.3x |
8.1x |
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 363
|
$10.1B |
37.8x |
-281.6x |
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€103
|
$9.4B |
2.3x |
6.5x |
Zhejiang NHU
|
China |
Biopharmaceuticals,
Nutraceuticals & Cosmeceuticals
|
CNY 22
|
$9.4B |
3.0x |
7.3x |
Aurobindo Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1155
|
$7.8B |
2.1x |
9.9x |
Lundbeck
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 38
|
$7.7B |
N/A |
N/A |
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$7.7B |
0.2x |
3.5x |
Kyowa Kirin
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2490
|
$7.6B |
2.2x |
9.5x |
Eisai Co.
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4128
|
$7.5B |
1.4x |
11.2x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$55
|
$7.5B |
6.7x |
10.5x |
Abbott India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Nutraceuticals & Cosmeceuticals
|
INR 31475
|
$7.4B |
9.9x |
36.7x |
Hikma Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£21
|
$7.3B |
2.2x |
8.4x |
Imeik Technology Development
|
China |
Biopharmaceuticals
|
CNY 182
|
$7.0B |
15.8x |
21.5x |
Hebei Changshan
|
China |
Biopharmaceuticals
|
CNY 52
|
$7.0B |
N/A |
N/A |
3SBio
|
Hong Kong |
Biopharmaceuticals
|
HKD 23
|
$6.7B |
4.5x |
10.2x |
China Resources Sanjiu
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 32
|
$6.6B |
1.6x |
8.6x |
Financiere de Tubize
|
Belgium |
Biopharmaceuticals
|
€129
|
$6.6B |
N/A |
N/A |
Biocon
|
India |
Biopharmaceuticals,
Contract Research & Manufacturing
|
INR 352
|
$6.5B |
3.5x |
16.9x |
Alkem Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 4847
|
$6.4B |
4.1x |
21.3x |
Wuxi XDC
|
Hong Kong |
Contract Research & Manufacturing,
Biopharmaceuticals
|
HKD 45
|
$6.3B |
9.7x |
33.3x |
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 3319
|
$6.3B |
14.1x |
44.6x |
Krka
|
Slovenia |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€188
|
$5.9B |
2.7x |
9.9x |
Yuhan
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 108247
|
$5.9B |
3.8x |
57.9x |
Shanghai RAAS
|
China |
Biopharmaceuticals
|
CNY 7
|
$5.8B |
4.9x |
15.8x |
Changchun High-Tech
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 112
|
$5.8B |
3.0x |
12.1x |
Glenmark Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1638
|
$5.5B |
3.4x |
19.2x |
PharmaEssentia
|
Taiwan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
TWD 546
|
$5.4B |
12.9x |
41.2x |
RemeGen
|
Hong Kong |
Biopharmaceuticals
|
HKD 70
|
$5.3B |
19.3x |
-44.0x |
ADMA Biologics
|
United States of America |
Biopharmaceuticals
|
$22
|
$5.2B |
11.2x |
26.2x |
Beijing Tiantan
|
China |
Biopharmaceuticals
|
CNY 20
|
$5.1B |
5.8x |
13.4x |
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$5.0B |
1.7x |
7.8x |
Shanghai Junshi
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 39
|
$4.9B |
15.7x |
-47.5x |
Bachem
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 55
|
$4.9B |
6.2x |
21.5x |
Dottikon ES Holding
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 290
|
$4.8B |
11.6x |
36.8x |
Ono Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1579
|
$4.7B |
1.4x |
6.1x |
Gedeon Richter
|
Hungary |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HUF 10130
|
$4.7B |
1.9x |
5.0x |
Aspen Pharmacare
|
South Africa |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ZAR 122
|
$4.6B |
1.9x |
8.3x |
Gan & Lee Pharmaceuticals
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 59
|
$4.6B |
9.1x |
34.2x |
Hypera
|
Brazil |
Biopharmaceuticals,
Drug Development & Therapeutics
|
BRL 28
|
$4.4B |
3.2x |
11.6x |
Zelgen Biopharmaceuticals
|
China |
Drug Development & Therapeutics,
Biopharmaceuticals
|
CNY 121
|
$4.3B |
46.4x |
-2875.8x |
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$31
|
$4.3B |
2.9x |
11.0x |
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$4.2B |
7.5x |
25.5x |
Kalbe Farma
|
Indonesia |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
IDR 1535
|
$4.1B |
2.0x |
13.4x |